European Pharmaceutical Review Issue 2 2026

Microbiology & contamination control

Our Micro/RMM In-Depth Focus examines how rapid microbiological methods are changing contamination detection and quality decision-making. We explore the integration of contamination control into pharmaceutical quality systems, alongside the potential of rapid PCR-based mycoplasma testing to accelerate detection in biotherapeutic manufacturing.

We also examine automated settle plate monitoring in aseptic environments, exploring how CFD, smoke visualisation and VHP studies can demonstrate airflow integrity and support more efficient environmental monitoring.

Manufacturing & operational performance

As pharmaceutical facilities become increasingly complex, manufacturers need to consider performance across the entire facility lifecycle. We examine how digital twins, integrated asset data and lifecycle intelligence can help address challenges around handover, compliance, maintenance and OEE – and why plants need to be designed for long-term performance rather than simply successful delivery.

Alongside this, we explore how modular serialization, weight control and tamper-evident labelling can help manufacturers meet evolving global requirements while building greater flexibility into production lines.

Formulation & drug delivery

As increasingly challenging APIs enter development, formulation strategies must evolve to address solubility and permeability limitations. We explore how powdered lipid surfactants could enhance oral bioavailability while offering new opportunities for tablet and capsule formulations.

Quality control & laboratory innovation

We examine the evolution of endotoxin testing, from traditional LAL methods to recombinant approaches, considering the regulatory landscape and key factors for selecting an assay in the modern QC microbiology laboratory.

Finally, we look towards the Lab of the Future, exploring how connected data, intelligent systems and Agentic AI could help laboratories move from reactive operations towards more predictive and informed decision-making.

Looking ahead

From rapid microbiology and contamination control to smarter manufacturing and intelligent laboratories, this issue explores how pharmaceutical organisations can adopt new technologies while maintaining the quality, compliance and control essential to modern operations.

This Issue is essential reading for technical decision-makers navigating the changing pharmaceutical landscape.

Interested? Register your details to find out more.